V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240000998 | 240012161 | 1.6 | 72.2 | null | 2019-03-31 | 2019-04-08 | ESHAP | 02 | Y | ALEMTUZUMAB + CYTARABINE + ETOPOSIDE + FLUDARABINE + LOMUSTINE + MELPHALAN | 101189260 |
| 240001153 | 240012162 | 0 | 70.8 | null | null | 2022-05-24 | null | null | null | RUXOLITINIB | 100890892 |
| 240002845 | 240012163 | 1.5 | 91.9 | null | 2020-12-09 | 2020-12-22 | CHLORAMBUCIL + OBINUTUZUMAB | 02 | null | UKALL2011 | 101713235 |
| 240000533 | 240012164 | 1.84 | 0 | null | 2020-01-24 | 2020-04-22 | AML MyeChild 01 A Mitozantrone/Cytarabine | 02 | null | CYTARABINE + RITUXIMAB | 100823555 |
| 240000713 | 240012166 | null | null | null | null | 2018-08-13 | CHOP R | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100494196 |
| 240000787 | 240012168 | 1.72 | 95.8 | null | null | 2018-11-17 | null | null | null | TRIAL UNSPECIFIED | 100335001 |
| 240000793 | 240012169 | 1.69 | 19.9 | null | null | 2018-10-11 | null | N | null | AML19 TRIAL | 101264579 |
| 240000816 | 240012171 | 1.82 | 45.7 | Curative (C) | null | 2019-04-11 | null | null | N | AZACITIDINE | 101346976 |
| 240000838 | 240012172 | 1.57 | 58.5 | null | null | 2019-05-23 | null | null | null | TRIAL UNSPECIFIED | 101718703 |
| 240000914 | 240012174 | 1.82 | 14 | null | 2021-12-06 | 2021-12-09 | IVE-R | 02 | null | LENALIDOMIDE | 100619343 |
| 240002845 | 240012176 | 1.79 | 55 | null | null | 2021-03-06 | FLUDARABINE + MELPHALAN | null | N | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101713235 |
| 240000793 | 240012180 | 1.65 | 0 | null | null | 2020-08-06 | null | 02 | null | BENDAMUSTINE + RITUXIMAB | 101264579 |
| 240000816 | 240012181 | null | null | null | null | 2019-04-11 | null | 2 | null | METHOTREXATE | 101346976 |
| 240000838 | 240012182 | 1.59 | 58.7 | Curative (C) | null | 2019-06-13 | null | null | N | RITUXIMAB | 101718703 |
| 240000914 | 240012184 | 1.78 | 57 | null | 2021-12-30 | 2022-01-08 | Methotrexate intrathecal | 02 | null | TISAGENLECLEUCEL (KYMRIAH) + FLUDARABINE + CYCLOPHOSPHAMIDE | 100619343 |
| 240000838 | 240012190 | 1.76 | null | null | null | 2020-06-14 | CHOP R - 21 days | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101718703 |
| 240000910 | 240012191 | 1.82 | 23.2 | Curative (C) | null | 2020-06-16 | null | null | N | METHOTREXATE | 100812971 |
| 240000914 | 240012200 | 1.84 | 52.6 | Curative (C) | null | 2022-02-12 | DA 3+8 | 02 | null | ALL UKALL2011 DEL INT C | 100619343 |
| 240000793 | 240012204 | 1.81 | 82.5 | null | 2021-01-29 | 2021-01-31 | THALIDOMIDE | N | null | TRIAL | 101264579 |
| 240000914 | 240012206 | 1.69 | 91.2 | null | 2022-02-12 | 2022-02-12 | ALL UKALL2011 Ind B Sht Dex (PAsp) | 01 | N | CYTARABINE + DAUNORUBICIN | 100619343 |
| 250000002 | 250000002 | 1.7 | 56.8 | Palliative (P) | 2016-02-28 | 2016-02-28 | Cetuximab 7 day (Cycle 1) | 02 | N | CISPLATIN + GEMCITABINE | 100151227 |
| 250000003 | 250000003 | 1.75 | 108 | Palliative (P) | 2019-04-27 | 2019-05-01 | null | 02 | N | CISPLATIN + GEMCITABINE | 100333687 |
| 250000005 | 250000005 | null | null | null | null | 2018-02-09 | null | null | null | CETUXIMAB + CISPLATIN + FLUOROURACIL | 100234945 |
| 250000008 | 250000008 | 1.78 | 71 | Palliative (P) | 2018-04-08 | 2018-05-08 | null | 02 | N | NB HRNBL-1 COJEC IND COURSE A | 101857459 |
| 250000013 | 250000013 | null | null | null | null | 2017-04-16 | null | null | null | CARBOPLATIN + PACLITAXEL | 100216419 |
| 250000015 | 250000015 | 1.75 | 59 | Palliative (P) | 2019-03-14 | 2019-03-14 | IPM | N | null | BCG | 101246053 |
| 250000025 | 250000025 | 1.7 | 76.1 | Adjuvant (A) | null | 2016-09-24 | null | 02 | N | CISPLATIN + GEMCITABINE | 101643041 |
| 250000035 | 250000035 | null | null | null | null | 2020-04-04 | null | null | null | IRINOTECAN + CISPLATIN + MITOMYCIN | 101483940 |
| 250000042 | 250000042 | null | null | null | null | 2019-10-13 | null | null | null | PACLITAXEL | 101515544 |
| 250000043 | 250000043 | null | null | null | null | 2019-07-08 | null | null | null | CISPLATIN + GEMCITABINE | 100126870 |
| 250000047 | 250000047 | null | null | null | null | 2019-09-06 | null | null | null | CARBOPLATIN + PACLITAXEL | 100976644 |
| 250000050 | 250000050 | null | null | null | null | 2018-11-16 | null | null | null | CISPLATIN + GEMCITABINE | 100480132 |
| 250000052 | 250000052 | 1.7 | 81.8 | Palliative (P) | 2018-11-03 | 2018-11-04 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101628973 |
| 250000057 | 250000057 | null | null | null | null | 2019-08-03 | null | null | null | CISPLATIN | 100257199 |
| 250000074 | 250000074 | null | null | null | null | 2019-02-22 | null | null | null | GEMCARBO | 101774587 |
| 250000080 | 250000080 | null | null | null | null | 2019-04-08 | null | null | null | CISPLATIN + GEMCITABINE | 100997006 |
| 250000084 | 250000084 | null | null | null | null | 2018-03-06 | null | null | null | BACILLUS CALMETTE-GUERIN | 100334374 |
| 250000099 | 250000099 | null | null | null | null | 2019-05-25 | null | null | null | CARBOPLATIN + GEMCITABINE | 101024356 |
| 250000104 | 250000104 | null | null | null | null | 2019-10-06 | null | null | null | PACLITAXEL | 101333075 |
| 250000108 | 250000108 | null | null | null | null | 2019-04-08 | null | null | null | CARBOPLATIN | 101732710 |
| 250000113 | 250000113 | null | null | null | null | 2017-11-13 | null | null | null | CARBOPLATIN + GEMCITABINE | 100954291 |
| 250000118 | 250000118 | null | null | null | null | 2019-03-10 | null | null | null | CETUXIMAB | 100457414 |
| 250000122 | 250000122 | null | null | null | null | 2019-06-01 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101784267 |
| 250000125 | 250000125 | null | null | null | null | 2018-12-12 | null | null | null | MITOMYCIN INTRAVESICULAR | 101351083 |
| 250000126 | 250000126 | null | null | null | null | 2021-04-19 | null | null | null | CISPLATIN + GEMCITABINE | 100921983 |
| 250000128 | 250000128 | null | null | null | null | 2020-02-27 | null | null | null | CISPLATIN + GEMCITABINE | 100880888 |
| 250000129 | 250000129 | null | null | null | null | 2019-02-25 | null | null | null | MITOMYCIN INTRAVESICULAR | 100287401 |
| 250000135 | 250000135 | null | null | null | null | 2019-12-21 | null | null | null | CISPLATIN + GEMCITABINE | 101416294 |
| 250000138 | 250000138 | null | null | null | null | 2017-12-12 | null | null | null | IMATINIB | 101704846 |
| 250000140 | 250000140 | 1.83 | 76.3 | Curative (C) | 2020-02-26 | 2020-02-27 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CARBOPLATIN + FLUOROURACIL | 101708220 |